Trial NCT01102218

View at ClinicalTrials.gov 
Org. Study IDs: 2010-01

Last trial update was posted on 2012-03-28

MeSH Interventions

Epoetin Alfa Pentoxifylline

MeSH Conditions

Anemia Kidney Diseases Kidney Failure, Chronic

Other Conditions

End Stage Renal Disease

Stopping Reasons

Lack of statistical difference between both arms of the trial.

Limitations And Caveats

Release of new FDA guidelines re target Hgb values impacted EPO dosing.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID